Eric Utt

460 total citations
26 papers, 354 citations indexed

About

Eric Utt is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Eric Utt has authored 26 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Eric Utt's work include Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Eric Utt is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Eric Utt collaborates with scholars based in United States, France and Canada. Eric Utt's co-authors include L. O. Ingram, C K Eddy, Kylie F. Keshav, Gregory G. Stone, Joseph M. Blondeau, Daniel F. Sahm, Harald Seifert, Charles D. Wells, Frederick D. Quinn and Paul R. Rhomberg and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Bacteriology and Annals of the New York Academy of Sciences.

In The Last Decade

Eric Utt

24 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Utt United States 12 107 96 95 91 71 26 354
Xuerui Bao China 7 164 1.5× 59 0.6× 238 2.5× 43 0.5× 29 0.4× 10 492
Farhad Nikkhahi Iran 14 113 1.1× 29 0.3× 158 1.7× 53 0.6× 46 0.6× 48 460
Michael Biggel Switzerland 15 172 1.6× 52 0.5× 145 1.5× 47 0.5× 89 1.3× 48 477
Nik Yusnoraini Yusof Malaysia 9 108 1.0× 54 0.6× 147 1.5× 18 0.2× 62 0.9× 26 398
Qili Gao China 6 87 0.8× 48 0.5× 97 1.0× 31 0.3× 37 0.5× 7 380
Luis Esaú López-Jácome Mexico 10 184 1.7× 30 0.3× 163 1.7× 16 0.2× 46 0.6× 43 403
Lequn Chen China 9 229 2.1× 151 1.6× 72 0.8× 73 0.8× 20 0.3× 9 462
Brankica Filipić Serbia 13 224 2.1× 19 0.2× 134 1.4× 39 0.4× 33 0.5× 35 453
Laura Ioana Popa Romania 9 162 1.5× 25 0.3× 208 2.2× 20 0.2× 45 0.6× 18 461
Lumyai Wonglakorn Thailand 9 92 0.9× 84 0.9× 176 1.9× 11 0.1× 42 0.6× 30 328

Countries citing papers authored by Eric Utt

Since Specialization
Citations

This map shows the geographic impact of Eric Utt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Utt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Utt more than expected).

Fields of papers citing papers by Eric Utt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Utt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Utt. The network helps show where Eric Utt may publish in the future.

Co-authorship network of co-authors of Eric Utt

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Utt. A scholar is included among the top collaborators of Eric Utt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Utt. Eric Utt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stone, Gregory G., Mark G. Wise, & Eric Utt. (2024). In vitro activity of ceftazidime–avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020. Microbiology Spectrum. 12(3). e0147323–e0147323. 1 indexed citations
4.
Kiratisin, Pattarachai, Marie Kempf, Gregory G. Stone, & Eric Utt. (2023). Ceftazidime-avibactam and comparators against Pseudomonas aeruginosa isolates collected globally and in each geographical region between 2017–2020. Journal of Global Antimicrobial Resistance. 34. 113–118. 4 indexed citations
5.
Utt, Eric, et al.. (2023). Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019. Journal of Global Antimicrobial Resistance. 33. 360–367. 1 indexed citations
6.
Gales, Ana Cristina, Gregory G. Stone, Daniel F. Sahm, Mark G. Wise, & Eric Utt. (2023). Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017–2019. Journal of Antimicrobial Chemotherapy. 78(7). 1606–1615. 21 indexed citations
7.
Sahm, Daniel F., et al.. (2023). Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019. Antimicrobial Agents and Chemotherapy. 67(5). e0140622–e0140622. 21 indexed citations
8.
Morrissey, Ian, Meng Xiao, Tianshu Sun, et al.. (2022). In vitro Activity of Isavuconazole and Comparators Against Clinical Isolates of Molds from a Multicenter Study in China. Infection and Drug Resistance. Volume 15. 2101–2113. 6 indexed citations
9.
Kempf, Marie, Francis F. Arhin, Gregory G. Stone, & Eric Utt. (2022). Ceftazidime-avibactam activity against Gram-negative respiratory isolates collected between 2018 and 2019. Journal of Global Antimicrobial Resistance. 31. 239–247. 7 indexed citations
10.
Kiratisin, Pattarachai, Francis F. Arhin, Gregory G. Stone, & Eric Utt. (2022). Antimicrobial Activity of Ceftazidime–Avibactam and Comparators Against Fluoroquinolone-Resistant Klebsiella pneumoniae Collected Globally from Antimicrobial Testing Leadership and Surveillance: 2018–2019. Microbial Drug Resistance. 28(11). 1019–1027. 1 indexed citations
11.
Seifert, Harald, et al.. (2022). Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018). Journal of Global Antimicrobial Resistance. 31. 82–89. 31 indexed citations
12.
Utt, Eric & Charles D. Wells. (2016). The global response to the threat of antimicrobial resistance and the important role of vaccines. Pharmaceuticals Policy and Law. 18(1-4). 179–197. 14 indexed citations
14.
Utt, Eric, et al.. (1995). The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization. Canadian Journal of Microbiology. 41(2). 152–156. 19 indexed citations
15.
Quinn, F D, et al.. (1995). Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever. Infection and Immunity. 63(6). 2317–2322. 13 indexed citations
16.
Weyant, Robbin S., F D Quinn, Eric Utt, et al.. (1994). Human Microvascular Endothelial Cell Toxicity Caused by Brazilian PurpuricFever-Associated Strains of Haemophilus influenzae Biogroup Aegyptius. The Journal of Infectious Diseases. 169(2). 430–433. 16 indexed citations
18.
Quinn, Frederick D., Robbin S. Weyant, Micah J. Worley, et al.. (1994). A Tissue Culture Model for Studying the Pathogenesis of Brazilian Purpuric Fever. Annals of the New York Academy of Sciences. 730(1). 260–262. 1 indexed citations
19.
Eddy, C K, Kylie F. Keshav, H. An, et al.. (1991). Segmental message stabilization as a mechanism for differential expression from the Zymomonas mobilis gap operon. Journal of Bacteriology. 173(1). 245–254. 29 indexed citations
20.
Utt, Eric. (1987). Strain Improvement of Aspergillus Ficuum NRRL 3153. Journal of International Crisis and Risk Communication Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026